GLPwatch
Trials (2101)
Page 26 of 36.
- A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India
- Comprehensive Clinical Evaluation Study of GLP-1RA
- To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo
- Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes
- Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
- Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc
- Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes
- Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity
- A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight
- Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease
- Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury
- Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss
- Multiple Ascending Dose Study of AMG 598 in Adults With Obesity
- Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian Subjects
- Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects
- A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of Semaglutide
- Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI
- Effect on Weight Loss of Exenatide Versus Placebo
- Comparison of Three Liraglutide Formulations in Healthy Volunteers
- Efficacy of Laparoscopic Sleeve Gastrectomy and Intensive Medical Management in Obese Type 2 Diabetes
- Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease
- Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)
- Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
- A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
- Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity
- Incretin Microdosing for Cardiometabolic Health in People With HIV
- Observational Study of ASCVD Risks of Type 2 Diabetes in East China
- Tirzepatide Weight Loss for MRD+ Early Breast Cancer
- Gut Hormones in Obesity, Nicotine and Alcohol Dependence
- A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With Liraglutide
- PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
- A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity
- The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients
- A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes
- Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
- Weight Loss and Physical Activity in Overweight/Obese Individuals With Knee Osteoarthritis
- A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times
- Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus
- A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term
- A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes
- A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity
- Study of Tirzepatide for Recovery and Alcohol Use Management
- A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants
- Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus
- Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment
- Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
- A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.
- A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.
- Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
- Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
- Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe HS Hidradenitis Suppurativa
- Liraglutide Treatment to Patients With Severe Renal Insufficiency
- Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity
- Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
- A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight
- A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
- Prevention of Progression of Prediabetes, Obesity and CV Risk
- A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet